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Composite Scaffolds for Bone Tissue Engineering 
 
Min Wang 
Department of Mechanical Engineering, The University of Hong Kong, Pokfulam Road, Hong Kong 
 
Abstract: Biomaterial and scaffold development underpins the advancement of tissue engineering. 
Traditional scaffolds based on biodegradable polymers such as poly(lactic acid) and poly(lactic acid-
co-glycolic acid) are weak and non-osteoconductive. For bone tissue engineering, polymer-based 
composite scaffolds containing bioceramics such as hydroxyapatite can be produced and used. The 
bioceramics can be either incorporated in the scaffolds as a dispersed secondary phase or form a thin 
coating on the pore surface of polymer scaffolds. This bioceramic phase renders the scaffolds bioactive 
and also strengthens the scaffolds. There are a number of methods that can be used to produce 
bioceramic-polymer composite scaffolds. This paper gives an overview of our efforts in developing 
composite scaffolds for bone tissue engineering. 
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INTRODUCTION 
 
 Since the late 1980s, tissue engineering (TE) as a 
new discipline has made rapid advances [1]. Tissue 
engineering, as a potential medical treatment, holds 
promises of (a) eliminating re-operations by using 
biological substitutes, (b) using biological substitutes to 
solve problems of implant rejection, transmission of 
diseases associated with xenografts and allografts, and 
shortage in organ donation, (c) providing long-term 
solutions in tissue repair or treatment of diseases, and 
(d) potentially offering treatments for medical 
conditions that are currently untreatable. Tissue 
engineering has therefore attracted great attention in 
science, engineering, medicine, and the society [2]. 
 It is now generally recognised that one of the key 
issues in tissue engineering is the development of 
suitable biodegradable materials and scaffolds for 
seeding cells and for the subsequent growth of tissues 
[3]
. For bone tissue engineering, major issues of tissue 
engineering scaffolds include the use of appropriate 
matrix materials for scaffolds, control of porosity and 
pore characteristics of scaffolds, mechanical strength of 
scaffolds, scaffold degradation properties, and 
bioactivity (i.e., osteoconductivity, or osteoinductivity 
if possible) of scaffolds. Biomaterials experience with 
biodegradable polymers in the pre-TE time (before 
1987 [4]) has heavily guided researchers towards using 
medical-profession-accepted and the US Food and Drug 
Administration (FDA)-approved biopolymers such as 
poly(lactic acid) (PLA) and poly(lactic acid-co-glycolic 
acid) (PLGA) for constructing tissue engineering 
scaffolds. In recent years, other polymers have also 
been developed for tissue engineering applications [5]. 
Despite their phenomenal developments in the past 
three decades [6], bioactive bioceramics (including 
glasses and glass-ceramics) have been overlooked for 
tissue engineering applications until recently. It has 
been shown that some bioactive glasses have the 
potential for bone tissue engineering [7] and there are 
now reports on the development of tissue engineering 
scaffolds purely made of bioceramics [8, 9]. 
 Compared to the strengths of metals and ceramics 
for medical applications, the strengths of biodegradable 
polymers are already very low. With the introduction of 
pores in the polymers to form tissue engineering 
scaffolds, the strengths of porous structures are further 
decreased, as strengths of materials decrease drastically 
with an increase in porosity [10]. On the other hand, 
polymers such as PLA and poly(ε-caprolactone) (PCL) 
are considered to be non-osteoconductive. In order to 
seek better scaffolds for bone tissue engineering, a 
composite strategy can therefore be adopted [11]. 
Polymer-based scaffolds containing bioactive 
bioceramics can be produced in which the bioceramics 
can serve two purposes: (a) making the scaffolds 
osteoconductive, and (b) reinforcing the scaffolds. With 
this composite strategy, there are two approaches for 
making bioceramic-polymer composite scaffolds: 
(1) incorporating bioceramic particles in the scaffold 
through a variety of techniques; and 
(2) coating a polymer scaffold with a thin layer of 
apatite through biomimetic processes. 
Both strategies have been employed in our efforts to 
develop usable scaffolds for bone tissue engineering. 
 
COMPOSITE SCAFFOLDS 
 
Particulate Bioceramics for Composite Scaffolds 
 
 Particulate materials of hydroxyapatite (HA), 
tricalcium phosphate (TCP) and a few bioactive glasses 
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can be used in composite scaffolds for achieving 
osteoconductivity [11]. In one of our early investigations, 
plasma-sprayed HA (psHA) particles were produced 
and used, as particulate psHA was found to be more 
bioactive than highly crystalline HA particles due to the 
amorphous component in psHA particles [12]. These 
spherical psHA particles were in the micrometer size 
range (Fig.1a). In our recent investigations, carbonated 
HA (CHA) particles were synthesized through a 
nanoemulsion process [13]. CHA is also more soluble 
and bioactive than highly crystalline HA due to the 
CO32- substitution in HA lattice [6]. Furthermore, the 
spherical CHA particles were in the nanometer size 
range (Fig.1b) and are thus more suitable for 
incorporation into polymers to form composite 
scaffolds. 
 
   
       (a) psHA microspheres       (b) CHA nanospheres 
Fig. 1: Particulate HA for composite scaffolds 
 
 
Fig. 2: Manufacture of bioactive composite scaffolds 
 
 
Fig. 3: Formation of bone-like apatite on a 
psHA/PLLA composite scaffold through 
immersion in a simulated body fluid 
 
Incorporating Bioceramic Particles in the Scaffolds 
 In our early investigations, psHA particles were 
incorporated in a poly(L-lactic acid) (PLLA) to form 
osteoconductive composite scaffolds [14]. The 
manufacturing process of these scaffolds is shown in 
Fig.2. In this process, freeze-drying was used at the 
final stage to produce the porous structure. Just as in the 
production of polymer scaffolds [15], for composite 
scaffolds, factors such as polymer solution 
concentration, porogen type and size, freeze-drying 
parameters, etc. play very important roles in forming 
the scaffolds of desired porous structures (pore 
geometry, pore size and size distribution, pore 
interconnectivity, thickness of pore walls, etc.) and 
hence the mechanical performance. It was shown 
through in vitro experiments that the composite 
scaffolds possessed bioactivity due to the incorporation 
of psHA particles (Fig.3). 
 In a recent study, it was shown that using an 
emulsion freeze-drying process, composite scaffolds 
based on polyhydroxybutyrate (PHB) and 
polyhydroxybutyrate-co-valerate (PHBV) natural 
polymers could be produced [16]. In these scaffolds, the 
CHA nanospheres (Fig.1b) were incorporated. Through 
this process, highly porous structure with a controlled 
pore morphologies could be achieved (Fig.4). 
 
 
Fig. 4: CHA/PHBV composite scaffold produced 
through an emulsion freeze-drying process 
 
 
Fig. 5: CHA/PHBV composite nanofibers produced 
through electrospinning 
 
 In recent years, biodegradable fibers which have 
diameters in the nanometer range have attracted great 
attention, as it is considered that the proper in vivo 
phenotype cannot be consistently achieved if cells are 
presented with fibers with diameters equal to or greater 
than the cell size. Among technologies for making 
polymer fibers of nanometer dimensions, 
electrospinning is the most appealing and the process is 
relatively simple. A study was recently conducted on 
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electrospinning of PHB and PHBV polymers and their 
composites [17]. It was found that electrospinning 
parameters (polymer solution concentration, solution 
feeding rate, injection needle diameter, electrical 
voltage, and working distance) all had significant 
effects on the resultant fibers. With careful 
experimentation, CHA/PHBV composite nanofibers 
containing CHA nanospheres could be produced 
(Fig.5). The incorporation of CHA nanospheres was 
confirmed through EDX analyses of the fibers. 
 Rapid prototyping (RP) technologies have become 
increasingly popular for producing tissue engineering 
scaffolds, as there are a few distinctive advantages of 
using RP technologies. One of our efforts is to use the 
selective laser sintering (SLS) technology to 
manufacture CHA/PLA composite scaffolds [18]. In the 
SLS route, there are two major issues: (a) obtaining 
powders of appropriate characteristics for sintering, and 
(b) minimizing the use of sintering powder. The latter 
issue could be solved by building and installing a 
miniature sintering platform in a commercial SLS 
machine. The former issue required the production of 
composite powders of suitable characteristics. Through 
a microemulsion process, both PLA and CHA/PLA 
composite powders were made (Fig.6). 
 
   
    (a) PLA microspheres     (b) CHA/PLA microspheres 
Fig. 6: Powders for producing composite scaffolds 
through selective laser sintering 
 
Coating the Polymer Scaffold with an Apatite Layer 
 
 As stated earlier, scaffolds made purely of 
biodegradable polymers such as PLA and PLGA are not 
osteoconductive. To impart bioactivity on the polymer 
scaffolds and also strengthen the scaffolds, apatite 
coatings could be formed on pores surfaces of the 
scaffolds before they are put in use for tissue 
engineering. For polymers, forming apatite coatings on 
their surfaces can be achieved through biomimetic 
processes. However, as polymers such as PLA degrades 
fast in the aqueous environment, normal biomimetic 
processes that have been developed for coating apatite 
on metals or ceramics [19] are not suitable for these 
polymers. Therefore, an accelerated biomimetic process 
was developed to coat PLLA scaffolds with a thin layer 
of apatite [20, 21]. Apatite was found to form on PGA 
meshes and PLLA scaffolds (Fig.7), and with a 
dynamic environment, biomimetic apatite coatings 
could be produced on pores inside the scaffolds. Further 
investigations revealed that a composite coating 
consisting of nano-sized apatite crystals and collagen 
which mimics bone structure could also be produced on 
PLLA scaffolds (Fig.8). It was found that the apatite 
coating and apatite/collagen composite coating could 
improve interactions between osteoblasts and PLLA 
scaffolds and that the composite coating was more 
effective than apatite coating in improving such 
interactions [22]. Fig.9 shows that osteoblast-like cells 
could attach and proliferate on the apatite/collagen 
coating formed on PLLA via the biomimetic process. 
 
 
Fig. 7: Bone-like apatite coating formed on the pore 
surface of a PLLA scaffold through an 
accelerate biomimetic process 
 
 
Fig. 8: Apatite/collagen composite coating formed on 
the pore surface of a PLLA scaffold through 
an accelerate biomimetic process 
 
 
Fig. 9: Osteoblast-like cells attaching to the 
apatite/collagen composite coating 
 
CONCLUDING REMARKS 
 
 Currently, there are a number of strategies for 
developing bone tissue engineering scaffolds. The 
composite strategy provides a means for achieving 
stronger and bioactive scaffolds as compared to 
conventional polymer scaffolds. The two approaches in 
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the composite route result in scaffolds of different, 
distinctive characteristics. Bioceramics obviously have 
an important role to play in constructing 
osteoconductive tissue engineering scaffolds. 
Systematic studies are required for the manufacture, 
characterisation, and in vitro and in vivo assessments of 
bioceramic-polymer composite scaffolds. Quite often, 
the scaffold manufacturing technology is selected 
together with considerations of choosing appropriate 
constituting materials of the composite. 
Osteoconductive composite scaffolds appear to have 
great potential for bone tissue engineering. 
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